Please use this identifier to cite or link to this item:
Title: Identification of biomarker in patients on high dose warfarin : an iTRAQ-coupled LC-MS/MS approach
Authors: Lee, Joanne Hui Yi.
Keywords: DRNTU::Engineering::Chemical engineering::Biotechnology
Issue Date: 2009
Abstract: Warfarin is a widely prescribed anticoagulant for the treatment and prevention of thrombotic diseases. Warfarin has a narrow therapeutic range and a given dose has more than 10-fold inter-individual variability in its pharmacodynamic effects. An insufficient dose may fail to prevent thromboembolism while an overdose increases the risk of bleeding. [4] Thus Warfarin therapy management is particularly challenging because of the difficulties inherent in achieving and maintaining the international therapeutic range (INR) in the therapeutic range required for anticoagulation. Current medical advancements have improved the dosing of Warfarin therapy through the use of genomic biomarkers where the metabolisms of Warfarin in relation to various patients are being studied. Both the CYP2C9 and VKORC1 gene have been approved by the FDA to be used when putting patients on Warfarin therapy. However genomic biomarkers are very often not as accurate as proteomic biomarkers and it is always expressed in forms of percentage inference. Since the human plasma consist of very broad dynamic range of protein relative abundances, it is believed that many important proteins such as biomarkers might have escaped detection due to past technologies. Coupled with the use of LC/MS-MS Machine, we manage to find 2 potential proteomic biomarkers in the plasma of patients undergoing Warfarin therapy namely 1) Unk1 Protein - Homo sapiens (Human) and 2) Apolipoprotein A-I precursor (Apo-AI) (ApoA-I) [Contains: Apolipoprotein A-I(1-242)] - Homo sapiens (Human).
Schools: School of Chemical and Biomedical Engineering 
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
  Restricted Access
1.16 MBAdobe PDFView/Open

Page view(s) 50

Updated on Jun 20, 2024


Updated on Jun 20, 2024

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.